CSPIA
EXAS

Cary Street Partners Investment Advisory’s Exact Sciences EXAS Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-100
Closed -$6.82K – 990
2023
Q3 		$6.82K Hold
100
– – ﹤0.01% 1405
2023
Q2 		$9.39K Hold
100
– – ﹤0.01% 1256
2023
Q1 		$6.78K Hold
100
– – ﹤0.01% 1239
2022
Q4 		$4.95K Buy
+100
New +$4.09K ﹤0.01% 1335

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Cary Street Partners Investment Advisory's EXAS Position: Q4 2023 in Review

Cary Street Partners Investment Advisory sold out of Exact Sciences (EXAS) in Q4 2023, closing a stake of 100 shares — an estimated $6.82K sold.

Cary Street Partners Investment Advisory first reported a position in EXAS in Q4 2022 and held it in 4 quarters. The position peaked at $9.39K in Q2 2023. 648 funds tracked by Wall St. Rank hold EXAS as of Q4 2023.

  • Cary Street Partners Investment Advisory reported no remaining Exact Sciences position as of Q4 2023 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 100 Exact Sciences shares in Q4 2023, an estimated $6.82K.
  • Cary Street Partners Investment Advisory first reported a position in Exact Sciences in Q4 2022 and held it in 4 quarters.
  • Cary Street Partners Investment Advisory's Exact Sciences position peaked at $9.39K in Q2 2023.
  • 648 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2023, filed 5 Feb 2024.